NAPRTCSNorth American Pediatric Renal Transplant Cooperative Study
References in periodicals archive ?
11] North American Pediatric Renal Trials and Collaborative Studies, NAPRTCS 2008 Annual Report: Renal Transplantation, Dialysis, Chronic Renal Insufficiency, 2008.
NAPRTCS calismasinda CMVIG profilaksi-sinin IVIG+antiviral tedaviye gore CMV hastaligina bagli hastaneye yatis sikligini azalttigi gosterilse de sonraki calismalarda bu yontemin CMV enfeksiyonunu azalttigi ancak CMV hastaligini azaltmadigi gosterilmistir (60).
Side effects of growth hormone seem to be few and are still under surveillance with careful documentation of the effects on bone and the risk of increased potential for transplant rejection (Ingulli & Tejani, 1994; Mehls, Tonshoff, Haffner, Wehl, & Schaefer, 1994; NAPRTCS, 1995).
Recombinant human growth hormone post-renal transplantation in children: a randomized controlled study of the NAPRTCS.
Table 1 Primary Etiologies of Kidney Disease in Children Congenital Structural (59%) * Obstructive uropathy * Aplasia/hypoplasia/dysplasia * Reflux nephrology * Polycystic kidney disease * Prune belly syndrome Inherited (3%) * Familial nephritis * Cystinosis * Primary oxalosis Acquired Inflammatory/immunologic (14%) * Focal segmental glomerulosclerosis * Systemic lupus erythematosus * Renal infarct * Chronic glomerulonephritis Infectious (4%) * Pyelonephritis * Hemolytic uremic syndrome Note: Adapted from NAPRTCS (2003).
The purpose of this retrospective study was to analyze the available longitudinal and multicenter data in the NAPRTCS database to evaluate the demographic and therapeutic risk factors and the trends for PTLD in children post renal transplantation.
A NAPRTCS report evaluating data from 2,237 pediatric patients found that 41% still had Hct levels <30% 6 months after starting dialysis (NAPRTCS, 2001).